drugset / Trial / NCT04331002

Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury

NCT04331002

Phase 2 Terminated 1 enrolled Austin V Stone
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if extended-release triamcinolone acetonide treatment alters the progressive changes in bone shape previously demonstrated after anterior cruciate ligament (ACL) reconstruction with partial meniscectomy or meniscal repair.

Timeline

Start
2020-08-21
Primary completion
2022-07-11
Completion
2022-07-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 32 mg Other

Indications

No indication recorded.